The RCVS is looking to recruit two veterinary surgeons as part-time Postgraduate Deans, to help oversee new veterinary graduates during their Professional Development Phase (PDP).
Freda Andrews, RCVS Head of Education said: "The PDP is an online recording system to guide new graduates as they work towards achieving the "year one competences" - the competences expected of a new graduate who's had about a year's experience in practice. Postgraduate Deans monitor PDP participants' progress and respond to their queries, and ultimately sign-off the graduates once their PDP is complete."
The roles have become available as two of the current post-holders, Stephen Ware and Professor David Noakes, wish to hand over to new colleagues. Both Stephen and David have served as Postgraduate Deans since 2007, when the PDP first became a requirement for all new veterinary graduates.
Stephen said: "Being a Postgraduate Dean gives you the opportunity to assist new graduates in the early stages of their career. It is also a way to encourage employers to take a responsible attitude towards new vets, particularly during their first job or two."
Postgraduate Deans are expected to spend up to 20 days a year working mainly online from home, and attend occasional meetings at the RCVS in London. They need experience of general practice, and to be used to dealing with and advising students, or employing and supporting new graduates. A sympathetic understanding of the challenges faced by newly qualified veterinary graduates is also required.
Further information about the role can be found at www.rcvs.org.uk/jobs, and information about the PDP, including a preview, at www.rcvs.org.uk/pdp.
Applicants should send a brief CV, and a covering letter setting out their relevant experience, to education@rcvs.org.uk by 7 March 2011.
Jack Fellows, Elanco swine sales leader, said: "With the potential zinc oxide restrictions coming into place next year, it’s crucial that vets work with their farmers to start trialling alternative PWD prevention strategies now, while the use of zinc is still permitted.
“Keeping PWD at bay going forward will require a multifaceted approach to piglet management. Gradually reducing the level of zinc oxide, while simultaneously incorporating alternative preventive techniques, will reduce the likelihood of problems arising during this transition.
“It’s far more convenient to have the vaccine in a 200 head dose, rather than the current pack size that offers 50 treatments. This will greatly cut down the time required to dilute and stabilise multiple individual packs, while helping to minimise any margin of error during administration."
Research has shown over 90% of farmers1 would head to their vet as the first port of call when it comes to advice on treating PWD.
“It’s crucial that vets are aware of all the preventive tools and options for managing the disease as over half of farmers surveyed2 also said they would treat PWD with antibiotics, which is obviously something we’re trying to steer away from as an industry, and why vaccines play such an important role going forwards.
“The Coliprotec vaccine is proven to prevent against these issues, delivering healthy pigs that reach a heavier market weight up to 7 days earlier3, while substantially reducing the in-nursery use of antibiotic treatments."
To mark the launch of the new 200 dose pack size, Elanco is offering veterinary practices the chance to buy five packs for the price of four, a total of 1000 doses, through their wholesaler.
For more information, contact Jack Fellows at jack_michael.fellows@elancoah.com or call 07771 798157.
References
An article in the August issue of the Society of Biology's magazine, The Biologist, has called for a complete prohibition of the trade in exotic pets.
The article was co-authored by Elaine Toland, Director of the Animal Protection Agency, Clifford Warwick, an independent biologist at Leeds University Medical School, and Phillip Arena, lecturer in biology at Murdocy University in Perth. It highlights PFMA figures showing that the population of reptiles in UK homes was 700,000 in 2009, 850,000 in 2010, and 800,000 in 2011. Meanwhile, the article estimates that 700,00 reptiles enter the UK pet trade system through importation and breeding each year, leading to the conclusion that the annual mortality rate for reptiles in the home is 75%.
In calling for the ban, the article also draws attention to the impact of the exotic pet trade on the ecosystem, problems caused by the release of non-native species into the environment, and the increased risk of zoonotic disease posed by the importation of exotic pets.
Elaine said: The fact that most reptiles die within a year is truly tragic, and is probably unresolvable because reptiles and captivity simply don't mix. The trade in wild-caught and captive-bred lizards, snakes, tortoises and turtles is wasteful, destructive and inhumane, and even the most conscientious and well-intentioned keepers cannot realistically provide for all these animals' biological needs. The public would never tolerate three out of four dogs dying annually in the home, and nor should we tolerate such premature mortality in reptiles. A ban on this high turnover trade in disposable animals is long overdue.
She added: "While trade bans on certain species have not solved all the problems associated with exotic pet trading, they are very effective and important and more are urgently required. We are not proposing a ban on the private keeping of exotic pets as this would be both very heavy-handed and create a whole new problem of what to do with all the animals. Rather, we want an end to the commercial trade supply so that existing problems wither gradually along with a dwindling captive population."
The BVA is also calling on Government to tighten pet import rules.
The advice follows news about a positive Brucella canis test in a rescue dog imported from Belarus in March this year.
The woman fostering the dog was hospitalised after coming into close contact with it, in the UK’s first confirmed dog-to-human transmission.
The foster animal and four pet dogs who were exposed to the disease, three of whom also tested positive, all had to be euthanised.
Data released by the Government shows a steep rise in confirmed Brucella canis cases since the start of 2020, rising from just three before that year to 107 till July this year.
The dogs were all either imported, had returned from holiday overseas, or been bred with an imported dog.
BVA is asking veterinary teams to:
British Veterinary Association President Justine Shotton said: “This recent case of Brucella canis in a foster dog is extremely tragic and highlights why vets have long raised concerns over the real and serious risks of importing ‘Trojan’ rescue dogs with unknown health histories into the UK.
“We know there is an added public health risk too, including for veterinary teams who treat and handle these animals, from contact with an infected dog’s contaminated body tissues and fluids.
"BVA continues to call on the Government to take urgent action to introduce stricter pet import measures, including mandatory pre-import testing, so we can minimise the spread of Brucella canis and other emerging diseases.
"We are also calling for the strengthening of enforcement provisions and checks on dogs brought into the country through the commercial route."
The 2021 B. canis risk view and statement by Public Health England (now UK Health Security Agency) contains vital information and recommendations for veterinary professionals: here:https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/960013/20210210_Brucella_canis_statement.pdf
BVA’s recommendations on tightening pet travel legislation: https://www.bva.co.uk/uploadedFiles/Content/News,_campaigns_and_policies/Policies/Companion_animals/BVA%20Position%20on%20Pet%20Travel%20Full.pdf
Dr Neil Bryant from the AHT, who is leading the research, said: "EHV is a major welfare concern for horses and foals and causes emotional, as well as financial strains, on horse owners and breeders around the world. It can strike any horse at any time so a vaccine will be of global welfare benefit to all horses, including the thoroughbred and sports horse breeding industries, and would help control this serious and sometimes fatal disease."
As a viral infection, EHV can cause respiratory disease, abortion or fatal illness in new born foals and neurological disease in adult horses, with signs ranging from slight wobbliness through to complete paralysis. The disease can strike any horse at any time because the virus, like other herpesviruses (such as the cold sore virus in humans), becomes dormant within most horses early in their life. It then re-emerges when the animal is later stressed such as when transported or mixed with new horses. A seemingly healthy pregnant mare may suddenly, and without warning, abort her unborn foal or may show signs of respiratory disease including mild fever, coughing and discharge from the nose. A horse which appears fit and well may suddenly show abnormalities when walking and within hours may be unable to stand.
Despite the potential severity and impact of outbreaks, there is still no vaccine that is licensed to protect against the neurological form of the disease and abortions still occur in highly vaccinated horse populations. The AHT says protection afforded by existing vaccines currently in use is sub-optimal, something that was highlighted by the 2016 abortion storm in Hertfordshire in fully vaccinated animals.
Neil added: "We have become aware of a pressing need for progress towards a new and improved EHV-1 vaccine. Just last month, the AHT was again called upon to work with the racing industry and affected parties in dealing with confirmed cases of EHV-1 abortion in premises in Yorkshire and Suffolk."
To that end, the charity has now established the Equine Industries EHV Vaccine Steering Group. Chaired by Professor Joe Brownlie of the RVC, the steering group includes world-renowned experts on both human and equine herpes viruses from a number of research establishments, who have concluded that the most appropriate way forward is for the AHT to design a modified live virus (MLV) vaccine.
After securing funding from a large number of organisations, including the Alborada Trust, EBM Charitable Trust, Horserace Betting Levy Board and the Racing Foundation, Paul Mellon Estate, Thompson Family Charitable Trust, Coolmore Ireland, Newsells Park Stud, Thoroughbred Breeders’ Association and Juddmonte Farms, the AHT has begun its five-year research programme.
Neil added: "We’re at the beginning of a very exciting and potentially ground-breaking vaccine development. Through our research, we will construct different viruses with attenuating mutations and assess their suitability as MLVs. We hope our findings will enable further development by vaccine manufacturers in creating an effective vaccine to protect against the serious clinical signs induced by EHV-1."
Noel Fitzpatrick of Channel 4 Supervet fame has been presented with an award by Guinness World Records after performing the world's first double 'bionic' leg implant on a cat.
The procedure, which was carried out on a cat called Oscar in 2009, was also the first time such implants had been placed into a moving joint.
The award was presented to Noel by Craig Glenday, Editor In Chief of Guinness World Records, at the London Pet Show.
Noel said: "The Guinness Book of Records was the first book I ever had, so receiving this award is a real honour! I'm very humbled, you're only as good as your next operation - you only ever think about providing hope to pets and their owners and doing your best. To be able to help them through the toughest times and see pets like Oscar make a full recovery is the most rewarding feeling and I'm thrilled that the work we carry out at Fitzpatrick Referrals has been recognised by Guinness World Records."
Practice Plan for Vets, a provider of client loyalty schemes to the veterinary profession, has signed with The Best Friends Group, one of the largest sole principal veterinary groups within the UK.
Best Friends is the latest veterinary group to introduce Practice Plan for Vets' Healthy Pet Plan, and will be rolling it out across its 32 veterinary sites. Healthy Pet Plans allow the owner to budget for the annual preventative health requirements of their pets whilst providing the veterinary practice with a regular income, secured client loyalty, improvements in client compliance and a much needed increase in client footfall.
Andrew Bennett (pictured right) is partnering with Practice Plan for Vets to advise on the promotion of Best Friends' membership plan and manage the pet owner direct debit collection process. Mike Hadfield from Practice Plan for Vets (pictured left) said: "Practices are realising that clients are shopping around for best price and value for many of the services and products that a practice competes for. When your clients pay monthly, their loyalty is improved significantly. With our veterinary focus, dedicated team and over twelve years' experience, our services are in high demand and are very appealing to all practices."
To find out more about Practice Plan for Vets, visit http://www.practiceplanforvets.co.uk/ or Stand 903 at BSAVA, or ring 0845 371 4495.
Xperior Farm Health, one of the bidders for the government contracts to provide TB testing, has announced that it mounted a legal challenge to the procurement process, but has now withdrawn that challenge in the face of the 'aggressive' timeframe in which Defra demanded that it submit its case.
Xperior says it was made aware last month that all five Delivery Partner contracts would be awarded to members of the same veterinary group (XL Vets), which it felt would both compromise competition and make Defra overly reliant on one service provider.
In addition, Xperior said it believed the successful bids were unfeasibly low, which presents a potentially devastating threat to the viability of many rural vet practices and a seriously reduced quality of TB testing service to farmers.
Xperior says it initially notified a formal query to the Animal and Plant Health Agency (APHA - the executive agency of Defra responsible for awarding the contracts) during the pre-announcement consultation period, and believes other bidders may have done likewise. The query was dismissed, as a result of which the company issued legal proceedings.
Xperior's Veterinary Director, Phil Elkins said: "We are concerned that proposed payment rates for TB testing are considerably lower than those proposed by other bidders, and at a level which questions the viability of practices continuing to provide TB testing services to their clients.
"The consequence would be either unfairly low payment rates for official veterinarians (OVs) who conduct TB testing, or an influx of inexperienced vets, potentially from other countries, into low paid positions. The loss of TB testing income would also challenge the viability of some rural veterinary businesses and the relationships held with their clients.
"Either way, this is contrary to a key tenet in the pre-tender documentation that Delivery Partners are expected to maintain a flow of TB testing work and revenue to contribute to the capability of the veterinary profession in rural areas to support food security and the rural economy."
Meanwhile, an APHA spokesperson said they were limited in how much they could say before the formal announcement of the award, except that: “APHA is confident in the robustness of the procurement process and that the selected bidders are the best candidates to deliver this vital service in the most effective way.”
VetSurgeon.org understands that now the legal challenge has been dropped, an official announcement of the winner will likely be made within days. However, it also seems likely that the payment rates for OVs will remain confidential even after the announcement of the award, so it may be some time before the prospects for OVs become clear.
Cat Henstridge, a small animal vet from South Yorkshire, has started a Facebook page to add the veterinary profession's voice to the campaign against the practice of puppy farming.
Cat said: "I write a blog on my website and recently touched on the subject of puppy farming. I was contacted by members of the 'PupAid' organisation and was shocked to learn that the veterinary community has no real public opinions on the subject. I found it really surprising that none of our professional bodies had spoken out, especially as we are supposed to be the bastions of animal welfare and see the consequences of poorly bred puppies all the time in our clinics."
"I am hoping the Facebook page will just be the start of a movement within the profession. Not only can we add our very powerful opinions to the discussion but this will be a way of driving the general public into our clinics to ask our advice, before they purchase a poor quality, sickly puppy and find themselves in trouble.
"Please join the page, add your stories about these dogs (we all have one!). At the risk of sounding cheesy, by coming together, we can really make a difference!"
Vets Now Ltd, the provider of out-of-hours emergency vet care has announced the acquisition of Salus Quality Partnerships (QP), a Health and Safety service provider to the veterinary profession in the UK.
Vets Now says this acquisition will extend the range of its services aimed at improving the quality of life within the profession and supporting practices to run more efficiently.
Vets Now currently runs 50 emergency clinics throughout the country including two referral hospitals in Scotland and the South West of England. In recent years Vets Now has extended its offering to the profession to include business services aimed at supporting vet practices. These services include Lifelearn (Client Education & Compliance), Staff Training Services, RCVS Practice Standards support and Practice Web services.
Salus QP, which has been running for over 18 years, offers veterinary practices information and services to help them comply with Health and Safety legislation and an anaesthetic monitoring service.
Richard Dixon, Founder of Vets Now said: "Our core purpose at Vets Now has always been to improve the lives of vets and pets, and the recent addition of Salus QP will help to do exactly that. The Salus QP team, led by Mark Enright and Alison Clark, have extensive knowledge in their field and crucially they fully understand the issues as they specifically apply to veterinary practices. With Salus QP our aim is to keep it simple and practical, helping practices fulfil their obligations without letting the Health and Safety tail wag the practice dog. I am very much looking forward to working with both Mark and Alison in the future as we take a fresh and common sense approach to Health and Safety in our profession."
Mark Enright said: "Salus QP and Vets Now both share a strong commitment to the veterinary profession and I truly believe that together we will be greater than the sum of our parts. I look forward to a future of innovations and benefits for all, and to continue to form quality partnerships within the veterinary profession."
Vetoquinol has announced the launch of its new support package to help vets and owners manage canine epilepsy with Epiphen, the company's phenobarbital medication.
Each Epiphen support package contains:
Accurate information is vital to help control epilepsy patients and the Owner Record Manual will enable owners to keep on top of this information. It contains charts to monitor seizure frequency and patterns, medication changes, blood test results and seizure characteristics.
The new "ask the expert" scheme offers vets the opportunity to ask for advice on epilepsy cases. Email epiphen@vetoquinol.co.uk with the query (and your contact details) and you will be put in touch with a neurology expert at a leading referral centre. Vets can also contact the Technical Helpline on 0800 1698197.
The Seizure Reports for vets provide a much more detailed tool for use at initial presentation or for owners to fill in when seizures differ in character. There is a pad of 30 tear-off sheets in each Epiphen support package.
Simon Boulton, Epiphen product manager said: "We understand that epilepsy is an emotional condition and wanted to provide vets and owners with more than just a tablet. I am convinced that with the Epiphen Support Package we are providing them with the tools they need to make the most of epilepsy management."
Epiphen also offers a free phenobarbital monitoring service. There is a voucher in each 30mg pack and 2 in each 60mg pack.
For more details on the Epiphen Support Package, to obtain a free practice starter pack or get extra copies of materials, please contact Vetoquinol on 0800 1608197 or contact your Vetoquinol representative.
According to the BVA’s Voice of the Veterinary Profession survey, 9 out of 10 companion animal veterinary surgeons report that the number of brachycephalic dogs being brought into their practice has greatly increased over the past three years.
98% said they had treated brachycephalic dogs for conformation-related health problems in the past year, and that 56% of the brachycephalic dogs being brought into practice either had, or would have benefited from having treatment for conformation-related health and welfare problems.
49% of UK vets say that the high profile of brachycephalic breeds in social media and advertising is one of the main reasons that clients choose to get a brachycephalic pet.
The #breedtobreathe campaign includes a number of things designed to tackle the problem. Firstly, practices are urged not to use images of brachycephalic dogs in their own marketing materials and communications. In addition the BVA has prepared a toolbox with a template letter for you to send to companies and brands that use brachycephalic breeds in their advertising, together with a range of images and a video you can share on social media, such as Facebook.
BVA President John Fishwick said: "Several well-known brands that use images of flat-faced dogs, such as Costa Coffee, Heinz and Comic Relief, have responded positively to letters from BVA and individual members of the profession recently, and pledged to avoid using them in future campaigns. These seemingly small victories offer hope for greater and long-lasting change.
"While the veterinary profession is relatively small, its reach is significant and its role is critical to the health and welfare of not only animals, but the rest of society too. That is why we believe that it is important for the veterinary team to utilise its spheres of influence both online and offline, which includes avoiding mixed messages between what clients and the wider public are being told by vets and VNs in practice and what they were seeing in practice communications.
"We’re urging vets to continue speaking out on behalf of the animals that we swear an oath to protect, since we know that hearing first-hand from individual members of the vet-led team has a real impact on the brands in question. BVA will continue to support members in challenging irresponsible promotions using these breeds."
The BVA has drawn up a position statement which lists ten actions that veterinary practices can undertake to improve brachycephalic breeds’ health and welfare and promote responsible ownership:
For more information, visit: www.bva.co.uk/brachys.
Photo: ponpimonsa_bibi/Shutterstock
Fergus Allerton has become the Editor-in-Chief for Part A: Canine and Feline, whilst Joanna Hedley is the Editor-in-Chief for Part B: Exotic Pets.
For both formularies, the editorial panels have reviewed the drug monographs to make sure all the information is up to date.
Part A includes:
Part B includes:
BSAVA President, Sue Paterson said: "The BSAVA Small Animal Formulary is recognised as an invaluable asset for the small animal clinician and is one of the Association’s most useful member benefits. Busy small animal clinicians in both primary care and referral practice will find this evidence-based resource an invaluable help with immediate prescribing advice."
Eligible BSAVA members will receive a complimentary print copy of Part A: Canine and Feline, and those who renew their membership in 2020 will also receive Part B: Exotic Pets as a loyalty reward gift.
Both Part A and Part B are available:
For more information, visit: https://www.bsava.com.
The publishers say that many people who prescribe veterinary medicines or who handle them (or bodily fluids that may contain them or their active metabolites) are not aware of the potential harmful effects they can have on human reproduction.
'Handling Veterinary Medicines and Pregnancy' gives up-to-date, evidence-based guidance on which drugs and methods of handling are hazardous; information on the relevant regulations relating to the safe handling of such medicines; and practical guidance on avoiding harm in veterinary practice.
Veterinary Prescriber says that once you have completed the module, you will:
understand the principles of reproductive toxicity
understand how data on the harmful effects of medicines are generated
be aware of the evidence on reproductive harm in veterinary practice
understand what practical measures to take to avoid harm
know where to find helpful information on medicines and pregnancy
For more information, visit: https://www.veterinaryprescriber.org/subscribers/
The study was based on VetCompass anonymised clinical records from more than two million dogs under first opinion veterinary care in the UK in 2019.
The study applied causal inference methods to the analysis of random samples of 815 dogs with CCL rupture aged between 1.5- and 12-years-old to replicate a randomised clinical trial and explore the impact of the different treatment methods.
Balancing the arms of the study for variables including age, breed and bodyweight, the researchers compared the outcomes for the dogs who received surgical management for CCL ruptures to those that were managed non-surgically.
The results showed that dogs managed surgically were 25.7% less likely to show short-term lameness at 3 months post-diagnosis and 31.7% less likely to show long-term lameness at 12 months post-diagnosis than dogs managed non-surgically.
Surgically managed dogs were 38.9% less likely to have a pain relief prescription at 3 months post-diagnosis, 34.1% less likely at 6 months and 32.7% less likely at 12 months than dogs managed non-surgically.
The RVC says these findings also similarly demonstrate lower longer term pain in surgically managed dogs.
Camilla Pegram, VetCompass PhD student at the RVC and lead author of the paper, said: “This study used an exciting new approach that allowed us to determine ‘cause’ rather than being limited to ‘association’.
"Surgical management for CCL rupture is often considered as providing better outcomes than non-surgical management, but this study now provides an evidence base to support this.
"Whilst surgical management might not always be feasible for some dogs, the findings allow vets to quantify the benefit in their discussions with owners.”
https://doi.org/10.1016/j.prevetmed.2024.106165
Reference
The RCVS announced in a tweet yesterday afternoon that it will be retaining postnominals on the Register.
#RCVScouncil agrees to retain postnominals on Register. Proposals to improve clarity to come back to future meeting. — RCVS (@RCVS_UK) June 5, 2014
#RCVScouncil agrees to retain postnominals on Register. Proposals to improve clarity to come back to future meeting.
VetSurgeon understands that the proposals to improve clarity may yet involve some rationalisation of the postnominals that will be displayed, but that RCVS Certs and Diplomas will remain.
The decision represents something of a victory for Victoria Lilley’s campaign and yet another indication that under the stewardship of Nick Stace, the RCVS really is evolving to become a more open, responsive organisation.
A new study carried out by academics at the University of Bristol's Animal Welfare and Behaviour research group has revealed that chickens empathise. So, if you've wondered why the chicken crossed the road, it was probably to help a friend.
More specifically, the research - funded by the BBSRC Animal Welfare Initiative and published online in the Proceedings of the Royal Society B. - demonstrated that domestic hens show a clear physiological and behavioural response when their chicks are mildly distressed.
Researchers say the study is the first to demonstrate that birds possess one of the important attributes that underpins empathy, and the first study to use both behavioural and physiological methods to measure these traits in birds.
During one of the controlled procedures, when the chicks were exposed to a puff of air, the hens' heart rate increased and eye temperature decreased. The hens also changed their behaviour, and reacted with increased alertness, decreased preening and increased vocalisations directed to their chicks.
Some of these responses have previously been used as indicators of an emotional response in animals. In domestic chickens, time spent standing alert is associated with higher levels of fear. Previous research carried out by the same group has shown that hens also selectively avoid surroundings associated with high levels of standing and low levels of preening.
Jo Edgar, PhD student in the School of Veterinary Sciences, said: "The extent to which animals are affected by the distress of others is of high relevance to the welfare of farm and laboratory animals.
"Our research has addressed the fundamental question of whether birds have the capacity to show empathic responses.
"We found that adult female birds possess at least one of the essential underpinning attributes of 'empathy'; the ability to be affected by, and share, the emotional state of another."
The researchers say they used chickens as a model species because, under commercial conditions, chickens will regularly encounter other chickens showing signs of pain or distress due to routine husbandry practices or because of the high levels of conditions such as bone fractures or leg disorders.
Reference:'Avian maternal response to chick distress', J L Edgar, J C Lowe, E S Paul, C J Nicol, published online ahead of print Proceedings of the Royal Society B, 9 March 2011.
Picture:Gemma Richards, University of Bristol
Pfizer Animal Health and Central Veterinary Services are collaborating in a new venture to create a unified National Benchmarking Database open to all veterinary practices.
In what it says is an unprecedented move, Pfizer will integrate 15 years' worth of data from its Performance Index practice benchmarking service (formerly known as the Fort Dodge Index) with that of the Central Veterinary Services' Management Analysis Indices (MAI). These two benchmarking services have been in co-existence for a number of years, each using different databases. Combining the data from the participating practices within each benchmarking service will create a database of almost 300 practices, representing in excess of 10% of all UK companion animal and mixed practices. This, says the company, will provide a more accurate and relevant benchmarking of UK companion animal practice performance.
The first combined reports from this new National Database will be available in May providing a comprehensive analysis for the first quarter of 2012. For Performance Index practices, this will be available via a new web portal.
Participating practices will continue to access their reports and services independently via their respective portals for PI and MAI, but will benefit from the larger database providing greater accuracy, granularity and relevance of exactly who a practice chooses to benchmark itself against. This, in turn, should provide all participating practices with an even better understanding of both their critical success factors and where there are clear opportunities for growth. Pfizer says that as ever, practice data confidentiality will be guaranteed for all subscribing practices.
Ned Flaxman, Director Business Innovation, at Pfizer Animal Health said: "We have recognised that what veterinary practices really need is to be far more specific about who they benchmark themselves against. There is little relevance to a rural mixed practice in the Lake District employing 3 full time vets (FTVE) benchmarking themselves against a large 5 FTVE companion animal practice in the centre of Manchester - you are comparing apples and pears! My vision for creating the National Database was really to increase the business benefits of practice benchmarking and enable practices to compare apples with apples. With the new system, the large urban practice in Manchester should be able to compare its performance against other urban practices in the North of England employing 5FTVE!
"To ensure practices have accurate and relevant data from which to make informed decisions to grow and thrive in these turbulent conditions, the creation of a single national benchmarking database is the only sensible solution. Although we are effectively levelling the playing field by enabling other veterinary suppliers to offer benchmarking, we believe it is the right thing to do for veterinary practices and the market as a whole. For Pfizer Animal Health, the needs of our veterinary clients are the driving force for our business decisions, veterinary support services and product development."
Martin Barrow, Managing Director of Central Veterinary Services said: "We fully agree that a single benchmarking database is the right solution for the market. The creation of this National Database, open to all practices irrespective of their supplier, will provide the participants with unique tools to give them powerful insights for their practices' future continued success.
"MAI and the Performance Index have competed with each other for years and provided a very useful added value service for their respective subscribers but when we were approached to integrate the two databases, we immediately saw the bigger picture and recognised the significant benefits this could bring to a wider audience of UK veterinary practices.
"The national database uses open standards for data collection and data is accepted from all practices irrespective of which practice management system they use. We believe it is the right thing to do for veterinary practices and brings significant benefits to the whole veterinary profession."
Practices are urged to subscribe to the PI or MAI services either independently or through one of their practice development partners. Although run from a common database each service will continue to be provided with its own unique features.
For further information on Performance Index practices should contact their Pfizer Account Manager, email Pfizer at Vetsupportplusuk@pfizer.com.
For further information on MAI, practices should contact Central Veterinary Services at mai@centralvet.com, or telephone 01359 245310
A former pet industry nutritionist has created a stir in the national newspapers with the launch of whichdogfood.co.uk, a website which dismisses veterinary diets as no different to the "awful" standard pet foods sold in pet stores and supermarkets.
According to reports in the Daily Mail, Daily Telegraph and Daily Express, David Jackson says the objective of his website is to change the way people buy pet food because "pet food manufacturers have been able to get away with producing frankly awful foods for our pets."
Explaining why veterinary surgeon sell prescription diets, Mr Jackson trots out some well known arguments which will be familiar to anyone who has followed the propaganda put out by the raw meaty bones (RMB) lobby: that veterinary surgeons are not taught enough about nutrition; that those training modules that exist are largely sponsored by manufacturers, and that veterinary practices benefit from 'massive cash incentives' from the manufacturers and distributors of veterinary diets.
Mr Jackson does say that there are exceptions to the rule, notably those veterinary diets developed to help pets with intolerance, allergies or uroliths.
Zoetis has announced the launch of Simparica, a once-monthly oral medication for the treatment of flea, tick and mite infestations in dogs beginning at eight weeks of age.
The company says the new product, which comes in the form of a tasty chewable tablet, acts quickly and provides continuous protection for 35 days without losing efficacy at the end of the month.
Simparica is effective against both Ctenocephalides felis and Ctenocephalides canis flea infestations in dogs.² It starts to kill fleas quickly within three hours³ and continues to kill fleas for at least 35 days², making it suitable as part of a treatment strategy for Flea Allergic Dermatitis.
The product also protects dogs against infestations with the most common ticks found to infest dogs in Europe2,4, including Dermacentor reticulatus, the species associated with the disease babesiosis, which has recently been reported in the UK. It’s also the only treatment for Ixodes hexagonus, one of the most prevalent ticks in the UK. The killing effect against Ixodes ricinus starts within 8 hours after a single oral administration and over 96% are killed within 24 hours.4
Zoetis says Simparica is also effective against Rhipicephalus sanguineus, and Sarcoptes scabiei, and that laboratory evidence shows efficacy for Demodex Canis and Otodectes Cynotis.
Zoetis believes that Simparica’s ability to provide continuous protection up to and beyond the monthly treatment period is very important for pet owners. Sixty three per cent of owners confess to giving flea and tick treatment later than when it was due, with the median being 5 days late.¹ Simparica gives vets and forgetful pet owners the peace of mind of extended duration of activity helping to minimise the potential risk of protection gaps.
Ned Flaxman, companion animal business unit director at Zoetis said: "With Simparica, we bring to the market an advanced parasiticide solution, helping to deliver improved client and pet owner satisfaction. The chewable tablets are easy to administer and readily accepted by dogs. But more importantly, Simparica helps vets and dog owners minimise the potential risk of protection gaps, as it acts very fast to kill fleas and ticks and performs for at least 35 days without losing efficacy — well beyond the monthly treatment period.
"With its rapid onset, robust duration of activity and very good safety profile, Simparica is the only oral isoxazoline indicated for four species of ticks in Europe including Ixodes hexagonus and the two species of fleas, dogs are most frequently infested with. Unlike most treatments, Simparica protects from both types of ectoparasites for the same duration."
For more information please speak to your account manager or contact customer support on 0854 300 8034.
The company says the acquisition is a natural fit for its behavioural range and will bolster its Adaptil portfolio with a wider variety of anxiety solutions for dogs.
Abbie King, senior behaviour product manager at Ceva Animal Health, said: “We have always been fans of the ThunderShirt range and we are therefore delighted with the acquisition, which will further strengthen our extensive portfolio of behavioural products that work in synergy with one another to provide pet owners with comprehensive anxiety solutions.”
For more information, visit: www.thundershirt.com
Eskimo, a reindeer at Edinburgh Zoo has received life-saving surgery just in time for Christmas, making him the first reindeer in history to receive keyhole surgery.
Vet Romain Pizzi successfully removed one of Eskimo's testes, which had been lodged in its abdomen since birth, using specialist surgical instruments donated to the zoo by one of Ark Surgical's strategic partners Surgical Innovations.
The zoo was worried that the retained testicle may have been developing into a tumour giving off abnormal hormones, and that this could become life-threatening. Thankfully, zoo surgeons found that the retained testicle, although abnormally sized, had not yet developed a tumour.
It is thought that the abnormal testicle was affecting Eskimo's production and flow of testosterone and, as a result, he was showing submissive behaviour and being bullied by the other male reindeer in the herd. He had also started to show some abnormal and delayed antler growth and development. Removing the testicle will halt any abnormal hormone production so hopefully Eskimo will return to full vigour just in time for Christmas.
Gavin O'Brien, Director at Ark Surgical said: "We were only too happy to help when Romain mentioned the challenging operation faced by Eskimo and in the season of goodwill we approached Surgical Innovations who kindly donated the instruments for this pioneering surgery."
Although laparoscopic surgery is routine in humans, the standard procedure in animals is still open abdominal surgery. Open abdominal surgery is 20 years behind human medical advances and has a number of negative factors on animals such as more post-operative pain, slower recovery and a higher risk of post-operative complications and infections.
Romain, a veterinary surgeon for the Royal Zoological Society of Scotland, based at Edinburgh Zoo, said: "Laparoscopic surgery is still very uncommon in veterinary medicine, even amongst common species such as dogs, cats and horses, so for keyhole surgery to be carried out on a reindeer shows a great advancement in veterinary surgery."
It is estimated that nearly one out of every two households in the UK are pet owners. Veterinary surgeons perform on average 600,000 open abdominal procedures annually but it is believed that less than 1% of vets currently practice laparoscopic surgery.
Romain believes that with the right instrumentation available through innovative companies such as Ark Surgical, UK vets now have more opportunity than ever to introduce laparoscopic techniques as part of their operating procedures.
Romain said: "This procedure was only really possible thanks to a cutting-edge designed retractor which we were able to use in this case. Ironically although a reindeer is a reasonably large animal, due to their unique anatomy and massive four chambered stomach that takes up most of the space in the abdomen, there is a very limited internal operating space. For this reason the operation was much more difficult than in a human, or in a dog, where there is more space to work, despite their smaller size."
"We were especially pleased with how quickly Eskimo recovered after surgery, he was standing and happily eating lichen again within 10 minutes of recovery from anaesthesia. He hardly seemed to notice he had even had surgery, although he was still slightly groggy from the anaesthesia. This would simply not have been possible with traditional open abdominal surgery, as the long wound would have been much more painful and debilitating."
The minimally invasive nature of laparoscopic surgery means there are numerous benefits for animals such as a reduction in post-operative pain, a faster recovery and reduced post-operative care. It also has a decreased risk of infection after surgery and a lower risk of any wound complications.
For veterinary surgeons laparoscopic surgery can offer better visualisation of the operated area, allowing them to be more precise and reach areas that are difficult to see in open surgery such as the liver and pelvic canal.
Romain carries out laparoscopic operations on dogs, cats and exotic pets at his own veterinary practice Inglis Veterinary Centre (Scotland) and has pioneered several new laparoscopic techniques.
He said: "Laparoscopic surgery has so many benefits for the animal, the veterinary surgeons and the zoo, so there is no reason why it should not be more common practice within veterinary surgery. I hope Eskimo's experience helps raise its profile and encourage more veterinary surgeons to look in to it as a standard surgical procedure."
Ark Surgical offers a wide range of laparoscopy instruments and peripherals to vets across the UK and to suit all budgets. The company says it is already working with many of the UK's leading vets and agencies such as the Royal Zoological Society of Scotland, as well as the UK foremost laparoscopic medical device manufacturer Surgical Innovations, to be at the forefront of veterinary laparoscopic surgery
For more information on animal laparoscopic surgery contact Ark Surgical on 01732 862882 or http://www.arksurgical.co.uk/
Invicta, the new, independent veterinary pharmaceutical company, has launched ChroMyco Duo, the first duo plate dermatophtye fungal test to help veterinary professionals identify the source of skin abnormalities in-house without the delay and cost of sending samples to a laboratory.
According to the Sussex-based company, ChroMyco Duo has been designed to aid practices in the accurate identification of fungal skin infections in dogs, cats, horses and all small animal species.
ChroMyco Duo is a dual plate test with dermatophyte test media (DTM) on one side and an Enhanced Sporulation Agar (ESA) on the other. Invicta says it's this dual test capability which greatly reduces the risk of false positive results. The test is performed by veterinary staff taking a pluck of fur or skin scrape from the lesion and innoculating both sides. After three to six days, if dermatophytes are present, the DTM will turn red and the ESA will turn blue-green.
Once a colour change is identified, a sample of the culture can be taken from the ESA, a media prolific in growing dermatophytes. Veterinary staff are then able to examine the fungus microscopically and identify the species of dermatophyte before advising on treatment.
Invicta has prepared a free fungal identification chart to assist practices with the identification of cultures and is providing free updates to subscribers, as images of new fungi are submitted by practices using the kit.
The ChroMyco Duo test is supplied in boxes of five units, each individually wrapped to allow a one year shelf life. It costs £5 per unit, which Invicta says makes it very cost-effective when compared to laboratory charges. It is incubated at room temperature so no specialist equipment is required.
Rob Watkins, Managing Director of Invicta, said: "The incidence of fungal infections in practice is significant and growing. Antifungal treatments already account for more than £1m sales in the UK veterinary sector. The problem is that dermatophyte presence is often misdiagnosed.
"Until recently vets have had to rely on either single test kit, or for a full diagnosis, by sending a sample to laboratory where tests cost up to £20 and can take 14 days to complete.
"With the launch of ChroMyco Duo, we're giving practices the capability to test reliably, simply and cost-effectively for the first time."
For further information on ChroMyco Duo or Invicta, please contact the company on 01403 791313 or email them at mail@invictavet.com.
Research commissioned by Bayer Animal Health has revealed that dogs really do look like their owners.
The research, which is being used to promote Drontal Bone, the company's new bone-shaped wormer, was conducted amongst 3,000 British dog-lovers. It found that the overwhelming majority of owners share at least one common physical attribute with their pet, whilst one in ten owners could be described as the spitting image of their dog, sharing six or more physical attributes:
As part of the campaign, Bayer has launched the Give Your Dog a Bone competition, a nationwide search to find the UK's "Top Dog". The competition is split into four video and photographic categories, with one open exclusively to dogs that have formed a special bond with their owner. Top dogs can enter via the competition website - www.giveyourdogabone.co.uk - where owners can upload photos, videos, and explain in under 100 words why they think their pet should win a Drontal 'Bonies' award.
Give Your Dog a Bone Judge Emma Milne MRCVS, said: "When dogs seem to have the same characteristics as their owners, it could be because people subconsciously choose a pet that resembles themselves. It is often found that more energetic breeds, such as s Red Setter have an owner who is sporty and most happy when taking their pet on long country walks, while a glamorous owner who enjoys grooming themselves might choose a dog which also requires lots preening, such as a Maltese Terrier. The Give Your Dog a Bone awards give us the chance to recognise the unique traits and talents that make dogs such an important part of our lives. With four very different categories, this competition will be wide open to dogs of all shapes, sizes and personalities!"
Interested parties are invited to share their views by the 2nd May 2018.
The ban is being explored by the government as part of a package of reforms designed to drive up animal welfare standards.
A number of other measures to tighten up the regulation of puppy breeders are also being laid before Parliament today, to come into force later in the year:
Banning licensed sellers from dealing in puppies and kittens under the age of eight weeks;
Ensuring that licensed dog breeders show puppies alongside their mother before a sale is made;
Tackling the sale of weak underage puppies and the breeding of unhealthy dogs and dogs with severe genetic disorders;
Introducing compulsory licensing for anyone in the business of breeding and selling dogs;
Requiring puppy sales to be completed in the presence of the new owner, preventing online sales where prospective buyers have not seen the animal first;
Insisting licensed dog breeders can only sell puppies
Environment Secretary Michael Gove said: "We need to do everything we can to make sure the nation’s much loved pets get the right start in life. From banning the sale of underage puppies to tackling the breeding of dogs with severe genetic disorders, we are cracking down on sellers who have a total disregard for their dogs’ welfare.
"This is a further step to raise the bar on animal welfare standards. We are also introducing mandatory CCTV in all slaughterhouses and increasing maximum prison sentences tenfold for animal abusers."
BVA President John Fishwick said: "As vets, we see first-hand the tragic consequences that can result from poorly bred puppies so it’s encouraging to see the Government announce this raft of measures to improve dog welfare.
"We support the principle that puppies should not be sold by third parties, but this is a complex area that must consider advertising, internet sales and pet owners’ buying habits to ensure illegal puppy sales won’t be driven underground.
"Effective legislation must be backed by enforcement, so it’s essential that local authorities are equipped with adequate resources to help guarantee the welfare of millions of dogs across the UK.
The consultation can be found here: https://www.gov.uk/government/consultations/banning-third-party-sales-of-pets-in-england-call-for-evidence